CDC committee delays vote on who should get coronavirus vaccines first in ...

CDC committee delays vote on who should get coronavirus vaccines first in nationwide rollout until they know which shots might be approved earliest The Advisory Committee on Immunization Practices was expected to vote on who gets initial coronavirus vaccine doses on Tuesday Members delayed the vote until they learn more about which jabs have the best chance of being approved earliest Proposed groups for early vaccination include healthcare personnel, essential workers, those with high risk medical conditions and adults aged 65 and older The committee's next meeting is scheduled to take place from October 28 to October 29

By Mary Kekatos Senior Health Reporter For Dailymail.com

Published: 15:49 BST, 22 September 2020 | Updated: 15:54 BST, 22 September 2020

View
comments

A Centers for Disease Control and Prevention (CDC) committee is delaying a vote on who should get the coronavirus vaccine first in a nationwide rollout.

The Advisory Committee on Immunization Practices (ACIP), which develops guidelines for vaccine administration as well as schedules, was expected to vote virtually on Tuesday. 

A plan would be drafted on which groups would be allocated the initial doses of the initial shot - or shots - that are proven safe and effective. 

However, members say they want to wait and learn more about which inoculations have the best chance of being approved, The Wall Street Journal reported.  

The Advisory Committee on Immunization Practices was expected to vote on who gets initial coronavirus vaccine doses on Tuesday. Pictured: Volunteers are given the Moderna COVID-19 vaccine in Detroit, Michigan, October 5

The Advisory Committee on Immunization Practices was expected to vote on who gets initial coronavirus vaccine doses on Tuesday. Pictured: Volunteers are given the Moderna COVID-19 vaccine in Detroit, Michigan, October 5

There are more than 170 coronavirus vaccine candidates in various stages of development around the globe, according to the World Health Organization.

At least nine are currently in large-scale trials in humans to prove the jabs are both safe and effective. 

Two-US based companies, Moderna Inc and Pfizer Inc, are in late-stage trials and say they expect

read more from dailymail.....

NEXT Cancer-stricken Public Health England official slams ban on assisted dying